Article Text

Download PDFPDF
Growing evidence that HPV infection is associated with an increase in HIV acquisition: exploring the issue of HPV vaccination
  1. Anne F Rositch1,
  2. Patti E Gravitt1,2,
  3. Jennifer S Smith3
  1. 1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
  2. 2Perdana University Graduate School of Medicine, Serdang, Malaysia
  3. 3Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina, USA
  1. Correspondence to Dr Anne F Rositch, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St. Room E6133, Baltimore, MD 21231, USA; arositch{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The systematic review and meta-analysis by Lissouba and colleagues adds to mounting data showing a strong association between genital human papillomavirus (HPV) infection and the risk of HIV acquisition, with an estimated summary odds ratio of 2.0 (95% confidence interval 1.6 to 2.5) for HIV acquisition associated with any-HPV infection. The strongest reported estimates are specific to clearance of HPV infection, suggesting that the association between HPV and HIV acquisition may not be fully attributable to confounding by other sexually transmitted infections (STIs) or co-transmission.1 ,2 …

View Full Text


  • Competing interests AFR has no conflicts to disclose. PEG was a member of the Women's Health Scientific Advisory Board for Qiagen within the past 5 years and JSS has received consultancy and/or research grants from GSK, Hologic-Genprobe and Merck Corporation over the past 5 years.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles